/PVEN

PVEN Stock - Press Ventures, Inc.

Q: What is the analyst price target for PVEN?

Analyst price target information is not currently available for PVEN.

Q: What is PVEN's market cap?

Market capitalization information is not currently available for PVEN.

Basic Materials|Other Precious Metals|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PVEN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2010

FY2011

FY2012

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-5.12

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2012	FY2011	FY2010
Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A
Operating Income	$-26,907	$-35,582	$-7,251
Net Income	$-26,907	$-35,582	$-7,251
Net Margin	N/A	N/A	N/A
EPS	$-0.00	$-0.00	$-0.00

Company Overview

Press Ventures, Inc. owns rights to the cedar leaf oil diffusion (CLO-D) technology in Poland. The patented CLO-D technology converts the cedar leaf oil into a vapor, and enables the diffusion of vapors for the killing of bacteria, mold, and viruses, such as Anthrax and the H1N1 virus in buildings. It focuses to distribute its products through a network of air conditioning installation companies. The company was founded in 2010 and is based in Warsaw, Poland.

Frequently Asked Questions about PVEN

What is PVEN's current stock price?

Press Ventures, Inc. (PVEN) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for PVEN?

No analyst price targets are currently available for this stock.

What sector is Press Ventures, Inc. in?

Press Ventures, Inc. operates in the Basic Materials sector, specifically within the Other Precious Metals industry. The company is traded on the OTC exchange.

What is PVEN's market cap?

Press Ventures, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does PVEN pay dividends?

No, Press Ventures, Inc. does not currently pay a dividend to shareholders.